Tuberculosis News and Research

Latest Tuberculosis News and Research

WHO finds very high levels of drug-resistant TB in Russia, Moldova

"[T]he highest levels ever of drug-resistant tuberculosis (TB) have been found in Russia and Moldova," the WHO reports in research published in the February edition of the WHO Bulletin, but "the agency didn't have data from most of Africa and India, where tuberculosis rates are much higher," the Associated Press/USA Today's "Your Life" reports.

4 Feb 2012

DRC facing decline in donor funding, HIV treatment shortage

"The lives of thousands of HIV-positive people in the Democratic Republic of Congo (DRC) are at risk as the country faces declining donor funding and a severe shortage of HIV treatment, according to Medecins Sans Frontieres (MSF)," PlusNews reports.

4 Feb 2012

Kenyan AIDS official says country has sufficient funding to support programs through 2016

Kenya has sufficient funds to support HIV/AIDS treatment programs through 2016, the head of the National AIDS Control Council (NACC) said in a statement on Wednesday after activists protested on Monday in support of the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Star reports.

4 Feb 2012

Worldwide malaria death figures - a gross underestimate, finds latest research

According to latest research malaria kills twice as many people every year as formerly believed, taking 1.2 million lives and causing the deaths not only of babies but also older children and adults.

3 Feb 2012

Ensure future for Global Fund or 'forfeit' chance at 'AIDS-free generation'

"Beyond AIDS, the Global Fund is currently the largest donor in the world for tuberculosis and malaria programs. ... The question is not whether the Global Fund works, but how to ensure it keeps working for years to come."

3 Feb 2012

Media outlets examine Global Fund's future as it enters second decade

The Guardian examines the future of the Global Fund to Fight AIDS, Tuberculosis and Malaria as it enters its second decade, writing, "Despite its staggering successes -- including helping put 3.3 million people on AIDS treatment, 8.6 million on anti-tuberculosis treatment and providing 230 million insecticide-treated nets for the prevention of malaria -- the fund's recent troubles had threatened to overshadow its accomplishments as it prepared to mark a decade as the world's main financier of programs to fight these three global epidemics."

3 Feb 2012

Version of 'Goldilocks' gene could determine future treatment for TB patients

'Goldilocks' gene could determine best treatment for TB patients Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene, says an international research team from Oxford University, King's College London, Vietnam and the USA.

3 Feb 2012

Pilot program in Tanzania to improve TB detection shows promise, IRIN reports

"A pilot community program to improve [tuberculosis (TB)] detection in northern Tanzania has shown good results and could be replicated nationwide as the country seeks to improve its TB treatment and prevention systems," IRIN reports.

2 Feb 2012

Collapse of Global Fund would stall global health efforts

"The Global Fund's drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett," a senior fellow for global health at the Council on Foreign Relations, in Nature's "World View" column.

2 Feb 2012

All players involved with Global Fund must take responsibility for 'past failures,' future support

"The Global Fund to Fight Aids, Tuberculosis and Malaria has proved to be one of the world's most important and innovative multilateral funding agencies," a Financial Times editorial states.

1 Feb 2012

New general manager's banking background beneficial at Global Fund

In this post on the Center for Global Development's (CGD) "Global Health Policy" blog, Amanda Glassman, a research fellow and director of global health policy at CGD, explains why the banking background of the new general manager of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Gabriel Jaramillo, "should serve him well."

1 Feb 2012

Opinion pieces recognize Global Fund anniversary

Last week, the Global Fund to Fight AIDS, Tuberculosis and Malaria celebrated its 10-year anniversary. The following are summaries of two opinion pieces written in recognition of this milestone.

1 Feb 2012

Protesting Kenyans call for emergency donor conference to raise $2B for Global Fund

"Hundreds of HIV-positive Kenyans protested outside the European Union's Nairobi office on Monday, accusing the E.U. of causing unnecessary deaths by cutting funding to" the Global Fund to Fight AIDS, Tuberculosis and Malaria, AlertNet reports.

1 Feb 2012

NIAID, Aeras partner for Phase II clinical trial of TB vaccine

Aeras announces today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the United States National Institutes of Health (NIH), has joined as a partner for a Phase II proof-of-concept clinical trial of a tuberculosis vaccine candidate jointly developed by Aeras and Dutch biopharmaceutical company Crucell.

1 Feb 2012

$Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost$

Anti-malarial treatment available to millions of poor Nigerians at a fraction of its normal cost

Millions of poor Nigerians will gain access to the most effective combination treatment for malaria at a fraction of its current cost, following the successful conclusion of negotiations between the United Kingdom Department for International Development (DFID) funded Partnership for Transforming Health Systems (PATHS2) and a variety of international and national stakeholders in Nigeria this week.

31 Jan 2012

Boehringer Ingelheim, Lilly receive FDA approval for Jentadueto to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) has approved Jentadueto (linagliptin/metformin hydrochloride) tablets, a new tablet combining the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, and metformin.

31 Jan 2012

New general manager discusses future of Global Fund with Wall Street Journal

In an article examining recent developments at the Global Fund to Fight AIDS, Tuberculosis and Malaria, the Wall Street Journal interviews Gabriel Jaramillo, the Colombian-born Brazilian citizen and former CEO of Sovereign Bank who will become the fund's new general manager this week.

31 Jan 2012

GRANITE program to aid in development of new TB fighting methods

A Rutgers-Camden professor is using his expertise in computer science to aid in the development of new methods to fight tuberculosis.

31 Jan 2012

Leprosy pathogen exploits micro-RNAs to weaken immune response

A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.

30 Jan 2012

International Roadmap for TB Research outlines priorities

In this post in the PLoS "Speaking of Medicine" blog, guest blogger Christian Lienhardt, senior scientific adviser at the Stop TB Partnership and WHO, "discusses the International Roadmap for Tuberculosis (TB) Research, a framework outlining priority areas for investment in TB research."

30 Jan 2012